KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Assets: 2019-2025

Historic Return on Assets for BioNTech SE (BNTX) over the last 6 years, with Sep 2025 value amounting to -0.02%.

  • BioNTech SE's Return on Assets fell 1.00% to -0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.02%, marking a year-over-year decrease of 1.00%. This contributed to the annual value of -0.03% for FY2024, which is 7.00% down from last year.
  • Latest data reveals that BioNTech SE reported Return on Assets of -0.02% as of Q3 2025, which was down 2.49% from -0.02% recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Return on Assets peaked at 1.42% during Q1 2022, and registered a low of -0.04% during Q1 2025.
  • In the last 3 years, BioNTech SE's Return on Assets had a median value of 0.00% in 2024 and averaged 0.09%.
  • Its Return on Assets has fluctuated over the past 5 years, first spiked by 129bps in 2021, then tumbled by 94bps in 2023.
  • Quarterly analysis of 5 years shows BioNTech SE's Return on Assets stood at 1.40% in 2021, then tumbled by 65bps to 0.75% in 2022, then plummeted by 69bps to 0.06% in 2023, then fell by 9bps to -0.03% in 2024, then dropped by 1bps to -0.02% in 2025.
  • Its Return on Assets stands at -0.02% for Q3 2025, versus -0.02% for Q2 2025 and -0.04% for Q1 2025.